CLINICAL_TRIALS
trial_result
· 2023-06-07
Clinical Trial Update: Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis [Phase 2]
Summary
Phase 2 dose-escalation trial evaluating different concentrations of ZK 245186 in atopic dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED